Lucid Diagnostics (LUCD) Change in Receivables (2022 - 2026)
Lucid Diagnostics (LUCD) reported Change in Receivables of $46000.0 for Q1 2026, up 187.5% on a YoY basis from $16000.0 in Q1 2025, and down 52.08% quarter-over-quarter from $96000.0 in Q4 2025.
Lucid Diagnostics (LUCD) Change in Receivables (2022 - 2026) Analysis & Trends
Lucid Diagnostics has reported Change in Receivables for 5 years, with the latest figure at $46000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 187.5% year-over-year to $46000.0; the trailing twelve-month figure through Mar 2026 stood at $631000.0 (up 5158.33% YoY), and the FY2025 full-year result was $601000.0, changed N/A from the prior year.
- Change in Receivables for Q1 2026 stood at $46000.0, down from $96000.0 in the prior quarter.
- The five-year high for Change in Receivables was $312000.0 in Q2 2025, with the low at -$122000.0 in Q3 2024.
- Historically, Change in Receivables has averaged $28941.2 across 5 years, with a median of $10000.0 in 2023.
- The largest YoY upside for Change in Receivables was 1287.5% in 2024 against a maximum downside of 771.43% in 2024.
- Lucid Diagnostics' Change in Receivables stood at -$14000.0 in 2022, then surged by 271.43% to $24000.0 in 2023, then slumped by 70.83% to $7000.0 in 2024, then surged by 1271.43% to $96000.0 in 2025, then slumped by 52.08% to $46000.0 in 2026.
- The last three Change in Receivables figures came in at $46000.0 (Q1 2026), $96000.0 (Q4 2025), and $177000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Lucid Diagnostics | 149.20 Mn | 121.33 Mn | -325,000.00 | 46,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46,000.00 |
| Mar 31, 2026 | 46,000.00 |
| Dec 31, 2025 | 96,000.00 |
| Dec 31, 2025 | 96,000.00 |
| Sep 30, 2025 | 177,000.00 |
| Sep 30, 2025 | 177,000.00 |
| Jun 30, 2025 | 312,000.00 |
| Jun 30, 2025 | 312,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Sep 30, 2024 | -122,000.00 |
| Sep 30, 2024 | -122,000.00 |
| Jun 30, 2024 | 111,000.00 |
| Jun 30, 2024 | 111,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | 24,000.00 |
| Dec 31, 2023 | 24,000.00 |